Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF)

Journal of Steroid Biochemistry and Molecular Biology

Volumn 71, Issue 1-2, 1999, Pages 1-19

  Klinge, Carolyn M ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ANTIESTROGEN; CELL NUCLEUS RECEPTOR; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; ESTRADIOL; ESTROGEN RECEPTOR; GLUTATHIONE TRANSFERASE; LUCIFERASE; TAMOXIFEN AZIRIDINE;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA BINDING; EXPRESSION VECTOR; GENE REPRESSION; GENETIC TRANSFECTION; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIGAND BINDING; PROTEIN DOMAIN; REPORTER GENE;

ANIMALS; BINDING SITES; BREAST NEOPLASMS; CATTLE; CHICKENS; COUP TRANSCRIPTION FACTOR I; DNA-BINDING PROTEINS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LIGANDS; LUCIFERASES; OVALBUMIN; PRECIPITIN TESTS; PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; RECOMBINANT PROTEINS; REPETITIVE SEQUENCES, NUCLEIC ACID; REPRESSOR PROTEINS; RESPONSE ELEMENTS; TAMOXIFEN; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

BOVINAE; GALLUS GALLUS; MINK CELL FOCUS-FORMING VIRUS; RODENTIA;

EID: 0032754467     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(99)00124-7     Document Type: Article

References (74)

1. Katzenellenbogen B.S., Korach K.S. Editorial: A new actor in the estrogen receptor drama-enter ERβ Endocrinology. 138:1997;861-862.
2. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. The nuclear receptor superfamily: the second decade. Cell. 83:1995;835-839.
3. Beato M., Sanchez-Pacheco A. Interaction of steroid hormone receptors with the transcription initiation complex. Endocrine Rev. 17:1996;587-609.
4. V.C. Jordan, Tamoxifen treatment for breast cancer: concept to gold standard. Oncology (1997) 7-13.
5. Klinge C.M., Bambara R.A., Hilf R. What differentiates antiestrogen-liganded versus estradiol-liganded estrogen receptor action? Oncology Res. 4:1992;1073-1081.
6. Robertson D.W., Wei L.L., Hayes J.R., Carlson K.E., Katzenellenbogen J.A., Katzenellenbogen B.S. Tamoxifen aziridines: Effective inactivators of the estrogen receptors. Endocrinology. 109:1981;1298-1300.
7. Spencer T.E., Jenster G., Burcin M.M., Allis C.D., Zhou J., Mizzen C.A., McKenna N.J., Onate S.A., Tsai S., Tsai M.J., O'Malley B.W. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature. 389:1997;194-198.
8. Horwitz K., Jackson T., Bain D., Richer J., Takimoto G., Tung L. Nuclear receptor coactivators and corepressors. Mol. Endocrinol. 10:1996;1167-1177.
9. Katzenellenbogen B.S., Montano M.M., Ekena K., Herman M.E., McInerney E.M. Antiestrogens: mechanisms of action and resistance in breast cancer. Breast Cancer Res. Treat. 44:1997;23-38.
10. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohma L., Greene G.L., Gustafsson J.A., Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature. 389:1997;753-758.
11. Zamir I., Harding H.P., Atkins G.B., Horlein A., Glass C.K., Rosenfeld M.G., Lazar M.A. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol. Cell. Biol. 16:1996;5458-5465.
12. Nagy L., Kao H.-Y., Chakravarti D., Lin R.J., Hassig C.A., Ayer D.E., Schreiber S.L., Evans R.M. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A and histone deacetylase. Cell. 89:1997;373-380.
13. Hong S.-H., David G., Wong C.-W., Dejean A., Privalsky M.L. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA. 94:1997;9028-9033.
14. Ling B.C., Hong S.-H., Krig S., Yoh S.M., Privalsky M.L. A conformational switch in nuclear hormone receptors is involved in coupling hormone binding to corepressor release. Mol. Cell. Biol. 17:1997;6131-6138.
15. Li H., Leo C., Schroen D.J., Chen J.D. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT. Mol. Endocrinol. 11:1997;2025-2037.
16. Soderstrom M., Vo A., Heinzel T., Lavinsky R.M., Yang W.M., Seto E., Peterson D.A., Rosenfeld M.G., Glass C.K. Differential effects of nuclear receptor corepressor (N-CoR) expression levels on retinoic acid receptor-mediated repression support the existence of dynamically regulated corepressor complexes. Mol. Endocrinol. 11:1997;682-692.
17. Zhang X., Jeyakumar M., Petukhov S., Bagchi M.K. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor. Mol. Endocrinol. 12:1998;513-524.
18. Smith C.L., Nawaz Z., O'Malley B.W. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol. Endocrinol. 11:1997;657-666.
19. Webb P., Lopez G.N., Uht R.M., Kushner P.J. Tamoxifen activation of the estrogen receptor/AP-1 pathway. Mol. Endocrinol. 9:1995;443-456.
20. Uht R.M., Anderson C.M., Webb P., Kushner P.J. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element. Endocrinology. 138:1997;2900-2908.
21. Paech K., Webb P., Kuiper G.G., Nilsson S., Gustafsson J., Kushner P.J., Scanlan T.S. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science. 277:1997;1508-1510.
22. Porter W., Wang F., Wang W., Duan R., Safe S. Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression. Mol. Endocrinol. 10:1996;1371-1378.
23. Porter W., Saville B., Hoivik D., Safe S. Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol. Endocrinol. 11:1997;1569-1580.
24. Lee S.-K., Choi H.-S., Song M.-R., Lee M.-O., Lee J.W. Estrogen receptor, a common interaction partner for a subset of nuclear receptors. Mol. Endocrinol. 12:1998;1184-1192.
25. Johnson S.D., Liu X., Zuo F., Eisenbraun T.L., Wiley S.R., Kraus R.J., Mertz J.E. Estrogen-related receptorα1 functionally binds as a monomer to extended half-site sequences including ones contained within estrogen-response elements. Mol. Endocrinol. 11:1997;342-352.
26. Klinge C.M., Silver B.F., Driscoll M.D., Sathya G., Bambara R.A., Hilf R. COUP-TF interacts with estrogen receptor, binds to estrogen response elements and half-sites and modulates estrogen-induced gene expression. J. Biol. Chem. 272:1997;31465-31474.
27. Seol S., Hanstein B., Brown M., Moore D.D. Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner). Mol. Endocrinol. 12:1998;1551-1557.
28. Enmark E., Gustafsson J.-A. Orphan nuclear receptors-the first eight years. Mol. Endocrinol. 10:1996;1293-1307.
29. Joel P.B., Smith J., Sturgill T.W., Fisher T.L., Blenis J., Lannigan D.A. pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167. Mol. Cell. Biol. 18:1998;1978-1984.
30. Tsai S.Y., Tsai M.-J. Chick ovalbumin upstream promoter-transcription factors (COUP-TFs): Coming of age. Endocrine Rev. 18:1997;229-240.
31. Shibata H., Nawaz Z., Tsia S.Y., O'Malley B.W., Tsai M.-J. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT). Mol. Endocrinol. 11:1997;714-724.
32. Peale F.V., Ludwig L.B., Zain S., Hilf R., Bambara R.A. Properties of a high-affinity DNA binding site for estrogen receptor. Proc. Natl. Acad. Sci. USA. 85:1988;1038-1042.
33. Klinge C.M., Peale F.V. Jr, Hilf R., Bambara R.A., Zain S. Cooperative estrogen receptor interaction with consensus or variant estrogen responsive elements in vitro. Cancer Res. 52:1992;1073-1081.
34. Peale F.V. Jr, Ishibe Y., Klinge C.M., Zain S., Hilf R., Bambara R.A. Rapid purification of the estrogen receptor by sequence-specific DNA affinity chromatography. Biochemistry. 28:1989;8671-8675.
35. Pavlik E.J., Coulson P.B. Hydroxylapatite "batch" assay for estrogen receptor: Increased sensitivity over present receptor assays. J. Steroid Biochem. 7:1976;357-368.
36. Obourn J.D., Koszewski N.J., Notides A.C. Hormone- and DNA-binding mechanisms of the recombinant human estrogen receptor. Biochemistry. 32:1993;6229-6236.
37. Klinge C.M., Studinski-Jones A.L., Kulakosky P.C., Bambara R.A., Hilf R. Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements. Mol. Cell. Endocrinol. 143:1998;79-90.
38. Cooney A.J., Tsai S.Y., O'Malley B.W., Tsai M.J. Chicken ovalbumin upstream promoter transcription factor (COUP-TF) dimers bind to different GGTCA response elements, allowing COUP-TF to repress hormonal induction of the vitamin D3, thyroid hormone and retinoic acid receptors. Mol. Cell. Biol. 12:1992;4153-4163.
39. Abbondanza C., deFalco A., Nigro V., Medici N., Armetta I., Molinari A.M., Moncharmont B., Puca G.A. Characterization and epitope mapping of a new panel of monoclonal antibodies to estradiol receptor. Steroids. 58:1993;4-12.
40. Joel P.B., Traish A.M., Lannigan D.A. Estradiol-induced phosphorylation of Serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase. J. Biol. Chem. 273:1998;13317-13323.
41. Lin R.J., Nagy L., Inoue S., Shao W., Miller W.H. Jr, Evans R.M. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature. 391:1998;811-814.
42. Reese J.C., Katzenellenbogen B.S. Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens: studies using human estrogen receptor overexpressed in mammalian cells. Nucleic Acids Res. 19:1991;6595-6602.
43. Horscroft N.J., Roy P. Thermal denaturation of proteins for SDS-PAGE analysis by microwave irradiation. Biotechniques. 22:1997;224-226.
44. Klinge C.M., Traish A.M., Bambara R.A., Hilf R. Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor when the receptor binds estrogen response element DNA. J. Steroid Biochem. Molec. Biol. 57:1996;51-66.
45. Anolik J.H., Klinge C.M., Brolly C.L., Bambara R.A., Hilf R. Stability of the ligand of estrogen response element-bound estrogen receptor depends on flanking sequences and cellular factors. J. Steroid Biochem. Molec. Biol. 59:1996;413-429.
46. Klinge C.M., Traish A.M., Driscoll M.D., Hilf R., Bambara R.A. Site-directed estrogen receptor antibodies stabilize 4-hydroxytamoxifen ligand, but not estradiol and indicate ligand-specific differences in the recognition of estrogen response element DNA in vitro. Steroids. 61:1996;278-289.
47. Greene G.L., Sobel N.B., King W.J., Jensen E.V. Immunochemical studies of estrogen receptors. J. Steroid Biochem. 20:1984;51-56.
48. Klinge, C.M., in press. Estrogen receptor binding to estrogen response elements slows ligand dissociation and synergistically activates reporter gene expression. Mol. Cell. Endocrinol. 145.
49. Klinge C.M., Bodenner D.L., Desai D., Niles R.M., Traish A.M. Binding of type II nuclear receptors and estrogen receptor to full and half-site estrogen response elements in vitro. Nucleic Acids Res. 25:1997;1903-1912.
50. Gillesby B.E., Stanostefano M., Porter W., Safe S., Wu Z.F., Zacharewski T.R. Identification of a motif within the 5′ regulatory region of pS2 which is responsible for AP-1 binding and TCDD-mediated suppression. Biochemistry. 36:1997;6080-6089.
51. Kastner P., Mark M., Chambon P. Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life? Cell. 83:1995;859-869.
52. Qiu Y., Krishnan V., Piereira F.A., Tsai S.Y., Tsai M.-J. Chicken ovalbumin upstream promoter-transcription factors and their regulation. J. Steroid Biochem. Molec. Biol. 56:1996;81-85.
53. Landel C.C., Kushner P.J., Greene G.L. The interaction of human estrogen receptor with DNA is modulated by receptor-associated proteins. Mol. Endocrinol. 8:1994;1407-1419.
54. Boonyaratanakornkit V., Melvin V., Prendergast P., Altmann M., Ronfani L., Bianchi M.E., Taraseviciene L., Nordeen S.K., Allegretto E.A., Edwards D.P. High-Mobility Group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol. Cell. Biol. 18:1998;4471-4487.
55. Driscoll M.D., Klinge C.M., Hilf R., Bambara R.A. Footprint analysis of estrogen receptor binding to adjacent estrogen response elements. J. Steroid Biochem. Molec. Biol. 58:1996;45-61.
56. Klinge C.M., Bambara R.A., Hilf R. Antiestrogen-liganded estrogen receptor interaction with estrogen responsive element DNA in vitro. J. Steroid Biochem. Molec. Biol. 43:1992;249-262.
57. Anolik J.H., Klinge C.M., Bambara R.A., Hilf R. Differential impact of flanking sequences on estradiol- versus 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA. J. Steroid Biochem. Molec. Biol. 46:1993;713-730.
58. Wu Q., Li Y., Liu R., Agadir A., Lee M.-O., Liu Y., Zhang X.-k. Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization. EMBO J. 16:1997;1656-1669.
59. Shibata H., Spencer T.E., Onate S.A., Jenster G., Tsai S.Y., Tsai M.J., O'Malley B.W. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog. Horm. Res. 52:1997;141-164.
60. Zhang Z., Laping J., Glasser S., Day P., Mulholland J. Mediators of estradiol-stimulated mitosis in the rat uterine luminal epithelium. Endocrinology. 139:1998;961-966.
61. Lin B.C., Won C.-W., Chen H.-W., Privalsky M.L. Plasticity of tetramer formation by retinoid X receptors: An alternative paradigm for DNA recognition. J. Biol. Chem. 272:1997;9860-9867.
62. Kersten S., Reczek P.R., Noy N. The tetramerization region of the retinoid X receptor is important for transcriptional activation by the receptor. J. Biol. Chem. 272:1997;29759-29768.
63. Schaeffer E., Guillou F., Part D., Zakin M.M. A different combination of transcription factors modulates the expression of the human transferrin promoter in liver and Sertoli cells. J. Biol. Chem. 268:1993;23399-23408.
64. Rohr O., Aunis D., Schaeffer E. COUP-TF and Sp1 interact and cooperate in the transcriptional activation of the human immunodeficiency virus type 1 long terminal repeat in human microglial cells. J. Biol. Chem. 272:1997;31149-31155.
65. Gronemeyer H. Control of transcription activation by steroid hormone receptors. FASEB J. 6:1992;2524-2529.
66. Reese J.C., Katzenellenbogen B.S. Examination of the DNA-binding ability of estrogen receptor in whole cells: implications for hormone-independent transactivation and the actions of antiestrogens. Mol. Cell. Biol. 12:1992;4531-4538.
67. Anolik J.H., Klinge C.M., Hilf R., Bambara R.A. Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence and ligand. Biochemistry. 34:1995;2511-2520.
68. Kerppola T.K., Curran T. The transcription activation domains of Fos and Jun induce DNA bending through electrostatic interactions. EMBO J. 16:1997;2907-2916.
69. Nardulli A.M., Grobner C., Cotter D. Estrogen receptor-induced DNA bending: orientation of the bend and replacement of an estrogen response element with an intrinsic DNA bending sequence. Mol. Endocrinol. 9:1995;1064-1076.
70. Romine L.E., Wood J.R., Lamia L.A., Prendergast P., Edwards D.P., Nardulli A.M. The high mobility group protein 1 enhances binding of the estrogen receptor DNA binding domain to the estrogen response element. Mol. Endocrinol. 12:1998;664-674.
71. Kato S., Sasaki J.H., Suzawa M., Masushige S., Tora L., Chambon P., Gronemeyer H. Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors. Mol. Cell. Biol. 15:1995;5858-5867.
72. Olson D.P., Koenig R.J. 5-Flanking sequences in thyroid hormone response element half-sites determine the requirement of retinoid X receptor for receptor-mediated gene expression. J. Biol. Chem. 272:1997;9907-9914.
73. Mader S., Leroy P., Chen J.Y., Chambon P. Multiple parameters control the selectivity of nuclear receptors for their response elements. Selectivity and promiscuity in response element recognition by retinoic acid receptors and retinoid X receptors. J. Biol. Chem. 268:1993;591-600.
74. Wood J.R., Greene G.L., Nardulli A.M. Estrogen response elements function as allosteric modulators of estrogen receptor conformation. Mol. Cell. Biol. 18:1998;1927-1934.